Skip to main content

Table 1 SOX2 expression in primary carcinoma (DCIS and invasive carcinoma) and lymph node samples

From: Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

  N total Score 0 Score 1 Score 2 Score 3
DCIS 9 5 (55.6%) 1 (11.1%) 2 (22.2%) 1 (11.1%)
Invasive Carcinoma 86 62 (72%) 11 (12.8%) 5 (5.8%) 8 (9.3%)
Lymph nodes 18 9 (50%) 4 (22.2%) 1 (5.5%) 4 (22.2%)
  1. DCIS: ductal carcinoma in situ